<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">ymj-2229</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Особенности динамики показателей суточного мониторирования электрокардиограммы у больных с осложненным течением гипертонической болезни (ишемический инсульт) в сочетании с ишемической болезнью сердца</article-title><trans-title-group xml:lang="en"><trans-title>Features of dynamics of the electrocardiogram daily monitoring in patients with complicated course of hypertensive disease (ischemic stroke) in combination with coronary heart disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шимохина</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shimohina</surname><given-names>N. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шимохина Наталья Юрьевна – аспирант</p></bio><email xlink:type="simple">doctorkardiolog99@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петрова Марина Михайловна – д.м.н., проф., зав. кафедрой</p></bio><email xlink:type="simple">stk99@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савченко</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savchenko</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Савченко Елена Александровна – к.м.н., доцент</p></bio><email xlink:type="simple">lenasavchenko@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Красноярский государственный медицинский университет им. В.Ф. Войно-Ясенецкого</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>21</day><month>10</month><year>2025</year></pub-date><volume>0</volume><issue>1</issue><fpage>20</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шимохина Н.Ю., Петрова М.М., Савченко Е.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Шимохина Н.Ю., Петрова М.М., Савченко Е.А.</copyright-holder><copyright-holder xml:lang="en">Shimohina N.Y., Petrova M.M., Savchenko E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/2229">https://ymj.elpub.ru/jour/article/view/2229</self-uri><abstract><p>Обследовано 77 больных с осложненным течением гипертонической болезни в сочетании с ишемической болезнью сердца в остром периоде ишемического инсульта и через год после заболевания. В течение года большинство пациентов не принимало медикаментозной терапии или получало ее нерегулярно. По данным суточного мониторирования электрокардиограммы (холтеровское мониторирование) через год после развития ишемического инсульта у пациентов установлено прогрессирующее течение сердечно-сосудистой патологии.</p></abstract><trans-abstract xml:lang="en"><p>Holter monitoring was made in 77 patients with complicated course of hypertension in combination with coronary heart disease in the acute period of ischemic stroke and in a year after disease. In the course of year most of the patients did not accept drug treatment or they were treated not regularly.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>суточное мониторирование электрокардиограммы (холтеровское мониторирование)</kwd><kwd>гипертоническая болезнь</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>ишемический инсульт</kwd></kwd-group><kwd-group xml:lang="en"><kwd>holter monitoring</kwd><kwd>hypertension</kwd><kwd>coronary heart disease</kwd><kwd>ischemic stroke</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Артериальная гипертония - основной фактор риска инсульта (итоги 3 лет проведения регистра в Краснодаре) / О.С. Харакоз [и др.] // Кардиология. - 2002. - №10. – С. 31-35.</mixed-citation><mixed-citation xml:lang="en">Артериальная гипертония - основной фактор риска инсульта (итоги 3 лет проведения регистра в Краснодаре) / О.С. Харакоз [и др.] // Кардиология. - 2002. - №10. – С. 31-35.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гусев Е. И. Современный взгляд на проблему инсульта / Е. И. Гусев // Инсульт: прил. к Журн. неврол. и психиатрии им. С. С. Корсакова. - 2003. - № 9. - С. 3-5.</mixed-citation><mixed-citation xml:lang="en">Гусев Е. И. Современный взгляд на проблему инсульта / Е. И. Гусев // Инсульт: прил. к Журн. неврол. и психиатрии им. С. С. Корсакова. - 2003. - № 9. - С. 3-5.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Суслина З. А. Ишемический инсульт: кровь, сосудистая стенка, антитромботическая терапия / З. А. Суслина, М. М. Танашан, В. Г. Ионова. – М.: Мед. кн., 2005. - 248 с.</mixed-citation><mixed-citation xml:lang="en">Суслина З. А. Ишемический инсульт: кровь, сосудистая стенка, антитромботическая терапия / З. А. Суслина, М. М. Танашан, В. Г. Ионова. – М.: Мед. кн., 2005. - 248 с.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Фонякин А. В. Кардиологическая диагностика при ишемическом инсульте / А. В. Фонякин, З. А. Суслина, Л. А. Гераскина. – СПб.: ИНКАРТ, 2005. – 224 с.</mixed-citation><mixed-citation xml:lang="en">Фонякин А. В. Кардиологическая диагностика при ишемическом инсульте / А. В. Фонякин, З. А. Суслина, Л. А. Гераскина. – СПб.: ИНКАРТ, 2005. – 224 с.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Шнайдер, Н. А. Инсульт. Церебральные осложнения артериальной гипертонии: учеб. пособие / Н. А. Шнайдер, С. Ю. Никулина. – Ростов н/Д: Феникс; Красноярск: Изд. Проекты, 2007. – 320 с.</mixed-citation><mixed-citation xml:lang="en">Шнайдер, Н. А. Инсульт. Церебральные осложнения артериальной гипертонии: учеб. пособие / Н. А. Шнайдер, С. Ю. Никулина. – Ростов н/Д: Феникс; Красноярск: Изд. Проекты, 2007. – 320 с.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertens. – 2003. – V. 21, №6. – P. 1011-1053.</mixed-citation><mixed-citation xml:lang="en">2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertens. – 2003. – V. 21, №6. – P. 1011-1053.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol / B. Dahlof, R. B. Devereux [et al.] // Lancet. – 2002. – V. 359. – P. 995–1003.</mixed-citation><mixed-citation xml:lang="en">Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol / B. Dahlof, R. B. Devereux [et al.] // Lancet. – 2002. – V. 359. – P. 995–1003.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipin: the VALUE randomised trial / S. Julius [et al.] // Lancet. – 2004. – V. 363, №9426. – Р. 2022–2031.</mixed-citation><mixed-citation xml:lang="en">Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipin: the VALUE randomised trial / S. Julius [et al.] // Lancet. – 2004. – V. 363, №9426. – Р. 2022–2031.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the AngloScandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT–BPLA): a multicentre randomized controlled trial / B. Dahlof [et al.] // Lancet. - 2005. - V. 366, №9489. - P. 895-906.</mixed-citation><mixed-citation xml:lang="en">Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the AngloScandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT–BPLA): a multicentre randomized controlled trial / B. Dahlof [et al.] // Lancet. - 2005. - V. 366, №9489. - P. 895-906.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Randomised trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke and transient ischaemic attack. PROGRESS Collaborative Group // Lancet. - 2001. - V. 358, №9287. - P. 1033-1041.</mixed-citation><mixed-citation xml:lang="en">Randomised trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke and transient ischaemic attack. PROGRESS Collaborative Group // Lancet. - 2001. - V. 358, №9287. - P. 1033-1041.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Remme W. J. Secondary prevention of coronary artery disease and the choice of the ACE inhibitor why EUROPA and not PEACE / W. J. Remme // Cardiovasc. Drugs Ther. - 2007. - V.21, №6. - P. 405-407.</mixed-citation><mixed-citation xml:lang="en">Remme W. J. Secondary prevention of coronary artery disease and the choice of the ACE inhibitor why EUROPA and not PEACE / W. J. Remme // Cardiovasc. Drugs Ther. - 2007. - V.21, №6. - P. 405-407.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
